Acotec Scientific Holdings Limited has announced that it has received regulatory approval from the PRC National Medical Products Administration for its Peripheral High-pressure Balloon Dilation Catheter, Armoni-HP®. This device is intended for use in percutaneous transluminal angioplasty in peripheral blood vessels, including femoral, iliac, and renal vessels, and for treating stenosis in arteriovenous fistulas used for dialysis. The Armoni-HP® features a non-compliant balloon catheter with an ultra-high-strength fiber-composite design, offering reliable clinical performance with a working pressure of up to 40 atm. Acotec plans to initiate marketing activities in the PRC market at an appropriate time. Shareholders and potential investors are advised to exercise due care when dealing with the company's shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.